ClosedPublished 3 Nov 2022

Reaction Biology Corporation /
vivo Pharm, LLC

Reaction Biology takes over vivo Pharm’s U.S. operations

Price
$5.5m
Stage
Closed
Buy side: Reaction Biology Corporation
Buy sideReaction Biology Corporation
Target: vivo Pharm, LLC
Targetvivo Pharm, LLC
Source · 3 Nov 2022
Buy side: Reaction Biology Corporation
Buy sideReaction Biology Corporation
Target: vivo Pharm, LLC
Targetvivo Pharm, LLC
01 / BuyerReaction Biology Corporation
02 / Targetvivo Pharm, LLC
01

What happened

Reaction Biology Corporation purchased the U.S. operations of vivo Pharm, LLC from vivo Pharm Pty, Ltd. for $5.5 million in cash, subject to customary adjustments.

The acquired operations include laboratory facilities, equipment, employees, cell lines and drug discovery service capabilities.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Reaction Biology takes over vivo Pharm’s U.S. operations

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.